|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The anti-idiotypie antibody abagovomab in patients with recurrent ovarian cancer,A phase I trial of the AGO-OVAR显示文摘 | Pfisterer I Du Bois A Sehouli J | | 0，，： | 1 |
| 2 | Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells显示文摘 | Pfister O Oikonomopoulos A Sereti K I | 2008 | Circulation Re- search2008，103，8： | 1 |
| 3 | |3l-Integrin is up-regulated via Raci-dependent reactive oxygen species as part of the hypertrophiccardiomyocyte response显示文摘 | Hauselmann S P Rosc-Schliiter B I Lorenz V Plaisance I Brink M Pfister 0 | 2011 | Free Radic Biol Med2011，51，： | 1 |
| 4 | Novel role of cystic fibrosis transmembrane conductance regulator in maintaining adult mouse olfactory neuronal homeostasis显示文摘 | Pfister S Weber T Haertig W Schwerdel C Elsaesser R Knuesel I | 2015 | J Comp Neurol2015，523，3： | 1 |
| 5 | Olfactory expression of a single and highly variable Vir pheromone receptor-like gene in fish species 显示文摘 | Pfister P Rodriguez I | 2005 | Proc Nat! Acad Sci USA2005，102，15： | 1 |
| 6 | Resistance Mechanisms of Multi-resistant Pseudomonas Aeruginosa Str- ains from Germany and Correlation with Hypermutation显示文摘 | Henrichfreise B Wiegand I Pfister W | 2007 | Antimicrob Agents Chemother2007，51，11： | 1 |
| 7 | Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGOOVAR, the NCIC CTG, and the EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | 2006 | J Clin Oncol2006，24，29： | 1 |
| 8 | The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR) : A population - based study of incidence, symptoms and risk factors 显示文摘 | Steinlin M Pfister I Pavlovic J | 2005 | Neuropediatrics2005，36，2： | 1 |
| 9 | Gemcitabine plus carboplatin compared whit Carboplatin in patients with platinum-sensitive recurrent ovarian cancer:an intergroup trial of the AGO-OVAR,the NCIC CYG,and EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | 2006 | J Clin Oncol2006，24，2： | 1 |
| 10 | Gemcitabine/carbop latin(GC)vs carboplatinin(C)platinum sensitive recurrent ovariancancer(OVCA):results of a Gynecologic Cancer Intergroup randomized phase Ⅲ trial of the AGO OVAR,the NCIC CTG and the EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | 2004 | Proc Am Soc Clin Oncol2004，449，： | 1 |
| 11 | Cytoplasmic dynein nomenclature 显示文摘 | PFISTER K K FISHER E M GIBBONS I R | 2005 | Journal of Cell Biochemistry2005，171，3： | 1 |
| 12 | Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer显示文摘 | Pfisterer J Vergote I Du Bois A | 2005 | Int J Gynecol Cancer2005，15，1： | 1 |
| 13 | Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer显示文摘 | Pfisterer J Vergote I Du Bois A | 2005 | Int J Gynecol Cancer2005，15，1： | 1 |
| 14 | Gemeitabine plus carboplatin compared with carboplatin in patients with platinum - sensitive recurrent ovarian cancer: An intergroup trial of the AGO - OVAR, the NCIC CTG, and the EORTC GCG 显示文摘 | Pfisterer J Plante M Vergote I | 2006 | J Clin Oncol2006，24，29： | 1 |
| 15 | Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer:an intergroup trial of the AGO-OVAR,the NCIC CTG,and the EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | | 0，，29： | 1 |
| 16 | Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of theAGO-OVAR, the NCIC CTG, and the EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | 2006 | J Clin Oncol2006，24，： | 1 |
| 17 | Resistance mech- anisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation显示文摘 | Henrichfreise B Wiegand I Pfister W | 2007 | Antimicob Agents Chemother2007，51，11： | 1 |
| 18 | Gemcitabine pluscarboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer:an intergroup trial of the AGO-OVAR,the NCIC CTG,and the EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | 2006 | J Clin Oncol2006，24，29： | 1 |
| 19 | Gemeitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG,and the EORTC GCG显示文摘 | Pfisterer J Plante M Vergote I | 2006 | J Clin Oncol2006，24，29： | 1 |
| 20 | Injection of chemoattractants into normal cornea:a model of inflammation after alkali injury显示文摘 | Pfister R R Haddox J L Sommers C I | | 0，，09： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员